These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 15337801

  • 41. Administrative and claims records as sources of health care cost data.
    Riley GF.
    Med Care; 2009 Jul; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
    [Abstract] [Full Text] [Related]

  • 42. Direct and indirect costs associated with Dupuytren's contracture.
    Macaulay D, Ivanova J, Birnbaum H, Sorg R, Skodny P.
    J Med Econ; 2012 Jul; 15(4):664-71. PubMed ID: 22369346
    [Abstract] [Full Text] [Related]

  • 43. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
    Lim SJ, Kim HJ, Nam CM, Chang HS, Jang YH, Kim S, Kang HY.
    J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
    [Abstract] [Full Text] [Related]

  • 44. Costs and quality of life of patients with ankylosing spondylitis in Canada.
    Kobelt G, Andlin-Sobocki P, Maksymowych WP.
    J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660
    [Abstract] [Full Text] [Related]

  • 45. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
    Cordato DJ, Schwartz R, Abbott E, Saunders R, Morfis L.
    J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
    [Abstract] [Full Text] [Related]

  • 46. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [Abstract] [Full Text] [Related]

  • 47. Economic burden of metastatic bone disease in the U.S.
    Schulman KL, Kohles J.
    Cancer; 2007 Jun 01; 109(11):2334-42. PubMed ID: 17450591
    [Abstract] [Full Text] [Related]

  • 48. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K, Danchenko N, Gondek K, Schwartz B, Thompson D.
    Urol Oncol; 2007 Jun 01; 25(5):368-75. PubMed ID: 17826652
    [Abstract] [Full Text] [Related]

  • 49. Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting.
    Ollendorf DA, Lidsky L.
    Am J Ther; 2006 Jun 01; 13(6):502-6. PubMed ID: 17122530
    [Abstract] [Full Text] [Related]

  • 50. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR, Evans C, Russell MW.
    J Dermatolog Treat; 2005 Feb 01; 16(1):37-42. PubMed ID: 15897166
    [Abstract] [Full Text] [Related]

  • 51. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
    Osiri M, Maetzel A, Tugwell P.
    J Rheumatol; 2007 Jan 01; 34(1):57-63. PubMed ID: 17183621
    [Abstract] [Full Text] [Related]

  • 52. Measuring costs: administrative claims data, clinical trials, and beyond.
    Etzioni R, Riley GF, Ramsey SD, Brown M.
    Med Care; 2002 Jun 01; 40(6 Suppl):III63-72. PubMed ID: 12064760
    [Abstract] [Full Text] [Related]

  • 53. [Cost of colorectal cancer in France in 1999].
    Selke B, Durand I, Marissal JP, Chevalier D, Lebrun T.
    Gastroenterol Clin Biol; 2003 Jan 01; 27(1):22-7. PubMed ID: 12594362
    [Abstract] [Full Text] [Related]

  • 54. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently.
    Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Wolfe F.
    J Rheumatol; 2004 Aug 01; 31(8):1621-9. PubMed ID: 15290744
    [Abstract] [Full Text] [Related]

  • 55. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
    Hoy T, Singhal PK, Willey VJ, Insinga RP.
    Curr Med Res Opin; 2009 Oct 01; 25(10):2343-51. PubMed ID: 19650749
    [Abstract] [Full Text] [Related]

  • 56. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
    Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB.
    Vaccine; 2007 Jun 28; 25(27):5086-96. PubMed ID: 17544181
    [Abstract] [Full Text] [Related]

  • 57. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.
    J Infect Dis; 2005 Nov 15; 192(10):1720-6. PubMed ID: 16235169
    [Abstract] [Full Text] [Related]

  • 58. Economic cost of fecal incontinence.
    Xu X, Menees SB, Zochowski MK, Fenner DE.
    Dis Colon Rectum; 2012 May 15; 55(5):586-98. PubMed ID: 22513438
    [Abstract] [Full Text] [Related]

  • 59. Cost of work-related injuries in insured workplaces in Lebanon.
    Fayad R, Nuwayhid I, Tamim H, Kassak K, Khogali M.
    Bull World Health Organ; 2003 May 15; 81(7):509-16. PubMed ID: 12973643
    [Abstract] [Full Text] [Related]

  • 60. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
    Fu AZ, Jhaveri M.
    J Med Econ; 2012 May 15; 15(4):688-94. PubMed ID: 22397589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.